Paclitaxel plus cisplatin and fluorouracil (PCF) compared with paclitaxel plus oxaliplatin and capecitabine (POX) as first-line therapy for advanced gastric cancer

CHENG Xianping; HONG Qiaojun; CHEN Mo; WANG Zhanggui

doi:10.3969/j.issn.1009-0460.2013.06.014

Home>Articles>Paclitaxel plus cisplatin and fluorouracil (PCF) compared with paclitaxel plus oxaliplatin and capecitabine (POX) as first-line therapy for advanced gastric cancer

DOI: 10.3969/j.issn.1009-0460.2013.06.014

Paclitaxel plus cisplatin and fluorouracil (PCF) compared with paclitaxel plus oxaliplatin and capecitabine (POX) as first-line therapy for advanced gastric cancer

CHENG Xianping

HONG Qiaojun

CHEN Mo

WANG Zhanggui

Keywords：Gastric cancerChemotherapyPaclitaxelOxaliplatinCapecitabine

Publication Date：2013-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 539-543 )

Chinese Clinical Oncology

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2013,18(6)